Key facts
- Nanome’s last known valuation is $38.0M (Jun 2024).
- It has raised $18.4M; the latest was Later Stage VC in Feb 2026.
- Notable investors include Plug and Play Tech Center, Mana Ventures, Gaingels, University of California, CONNECT (San Diego) — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Nanome
- ·The full record, as it builds
Funding rounds
No funding rounds for Nanome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nanome
Operator of an AI-assisted scientific copilot and multi-user spatial computing platform designed to accelerate scientific discovery and drug discovery. The company's platform processes complex molecular data through immersive and collaborative applications that facilitate pattern recognition, molecular visualization, and an efficient drug design and drug discovery process, enabling medicinal chemists and structural biologists to understand complex molecular data and to collaborate and share results while securing their intellectual property through the blockchain.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2015
- Employees
- 18
- Website
- nanome.ai/
- Ownership
- Privately Held (backing)
Nanome doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nanome shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nanome in its N-PORT filings yet. We sweep new filings monthly.